People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Health Care, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cabaletta Bio, Inc. | — | Biotechnology | Series C | $88.3M | $2.0B | 2018 |
| BlinkBio, Inc. | — | Biotechnology | Series B | $43.6M | $20.8M | 2009 |
| ControlRad, Inc. | — | Other Health Care | Series A | $40.7M | $10.8M | 2012 |
| Mig Irc, Llc | — | Other Health Care | Seed | $5.7M | $86.0M | 2012 |
| Glmps Co. | — | Other Technology | Pre-Seed | $900K | $7.1M | 2023 |
| Tatoosh Distillery, Llc | — | Other | Pre-Seed | $498K | $11.5M | 2013 |
Mark Simon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Simon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Nichtberger | 2 | 3 |
| Ryan Drant | 1 | 24 |
| Geoff Smith | 1 | 6 |
| Sol Barer | 1 | 6 |
| Brian Daniels | 1 | 5 |
| David Shulkin | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Alan Lewis | 1 | 4 |
| Derek Small | 1 | 4 |
| Douglas Reed | 1 | 4 |
| James Schulz | 1 | 3 |
| Paul Mirabella | 1 | 3 |
| Harlan Weisman | 1 | 2 |
| Jutta Wanner | 1 | 2 |
| Kapil Dhingra | 1 | 2 |
| Justin Kirkpatrick | 1 | 2 |
| Michael Gargano | 1 | 2 |
| Viren Mehta | 1 | 2 |
| Dan Geffken | 1 | 1 |
| Aido Zairi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.